# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year.
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and lowers the price target from $120 to ...
Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.50...
Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a In-Line and raises the price targe...
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and lowers the price target from $134 to ...